National Health Investors (NYSE:NHI) has been given a $79.00 price objective by stock analysts at Stephens in a note issued to investors on Friday. The firm presently has a “buy” rating on the real estate investment trust’s stock. Stephens’ price objective would suggest a potential upside of 13.28% from the stock’s current price.

A number of other equities analysts have also recently weighed in on the company. KeyCorp reissued an “underweight” rating on shares of National Health Investors in a report on Tuesday, December 19th. Zacks Investment Research cut National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, November 17th. ValuEngine raised National Health Investors from a “hold” rating to a “buy” rating in a report on Friday, November 10th. Capital One Financial assumed coverage on National Health Investors in a report on Monday, October 23rd. They set an “equal weight” rating on the stock. Finally, BMO Capital Markets reissued a “hold” rating and set a $80.00 price objective on shares of National Health Investors in a report on Wednesday, October 18th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. National Health Investors has an average rating of “Hold” and an average target price of $80.00.

Shares of National Health Investors (NYSE NHI) traded down $1.37 during midday trading on Friday, hitting $69.74. The company had a trading volume of 303,010 shares, compared to its average volume of 215,131. The stock has a market cap of $2,900.00, a PE ratio of 17.44, a price-to-earnings-growth ratio of 3.36 and a beta of 0.59. The company has a current ratio of 12.72, a quick ratio of 12.72 and a debt-to-equity ratio of 0.84. National Health Investors has a 52 week low of $68.96 and a 52 week high of $81.60.

A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in National Health Investors by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock worth $498,323,000 after purchasing an additional 72,518 shares during the period. BlackRock Inc. increased its stake in National Health Investors by 6.6% in the 2nd quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock worth $280,927,000 after purchasing an additional 218,482 shares during the period. Northern Trust Corp increased its stake in National Health Investors by 6.4% in the 2nd quarter. Northern Trust Corp now owns 1,007,869 shares of the real estate investment trust’s stock worth $79,823,000 after purchasing an additional 60,784 shares during the period. State Street Corp increased its stake in National Health Investors by 8.5% in the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock worth $79,133,000 after purchasing an additional 78,355 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in National Health Investors by 4.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 588,733 shares of the real estate investment trust’s stock worth $45,504,000 after purchasing an additional 23,191 shares during the period. 70.08% of the stock is currently owned by institutional investors and hedge funds.

WARNING: “Stephens Analysts Give National Health Investors (NHI) a $79.00 Price Target” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/13/stephens-analysts-give-national-health-investors-nhi-a-79-00-price-target.html.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.